ScholarIQanswers from OpenAlex

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy

PaperCitations, authors & open-access status

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy have?

ScholarIQcitation count

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy has 534 citations in the OpenAlex counts ScholarIQ stores.

When was Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy published?

ScholarIQyear

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy has 2003 year in the ScholarIQ index.

What is the open-access status of Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy?

ScholarIQoa status

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy has bronze oa status in the ScholarIQ index.

What is the DOI of Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy?

ScholarIQdoi

The DOI for Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy is on the source record.

What is the PMID of Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy?

ScholarIQpmid

The PMID for Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy is on the source record.

What is the OpenAlex record for Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy?

ScholarIQopenalex

The OpenAlex for Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial